Immunicom Conference Highlights Innovation in Clinical Trial Design to Advance its Breakthrough Cancer Immunotherapy Platform
New “master protocols” approach expected to dramatically accelerate Immunicom’s clinical trial programs and therapeutic development of its novel subtractive immuno-oncology...